Please login to the form below

Not currently logged in
Email:
Password:

Pharmaceutical Market Europe - Febuary 2015

PME Febuary 2015

This month in PME we have an extended look at the recent decision by England’s Cancer Drugs Fund to cut back on the number of medicines it will support and Sanofi, Lilly, Roche and the ABPI give us their thoughts on the CDF's ‘de-listing’.

We also speak with Lisa Anson, president of AstraZeneca, on the value of personalised medicines, the struggle to gain access and working with the NHS.

Adherence comes under the microscope in our Model Behaviour feature, which confirms non-adherence as a complex exercise that begins and ends with the patient.

We also hear from Johnson & Johnson’s Sabine Dandiguian on diversity, innovation and becoming the first European business leader to pick up the HBA’s Luminary Award.

Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.

PME is also available to download as an app for iPhone and iPad

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Infographics